Component

Carbon-13-labeled cyanocobalamin tracer

Stable-isotope cyanocobalamin probe used in the 2024 bioavailability study; distinct from unlabeled cyanocobalamin.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. Adding calcium 500 mg to metformin 850 mg raised mean tracer bioavailability from 30.8% to 46.4% in seven healthy completers (p=0.003).

    Experimental context and source evidence
    cross_nutrient
    true
    experimental_model
    Seven healthy adult completers; three experimental days separated by one-month washouts
    exposure
    Metformin 850 mg plus calcium 500 mg and carbon-13 cyanocobalamin
    limitations
    Small acute tracer pilot in healthy adults; cannot establish prevention of chronic deficiency or identify the exact molecular metformin target. Doses describe the experiment, not advice.
    nutrient_topic
    Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
    organism
    Homo sapiens
    plain_language
    Calcium coadministration reversed the tracer reduction in this pilot.
    primary_references
    [muralidharan-2024-calcium] Effect of calcium supplementation on reversing metformin-based inhibition of vitamin B12 bioavailability in healthy adults using a [13C] cyanocobalamin tracer - A pilot study. (2024). https://pubmed.ncbi.nlm.nih.gov/38901951/ DOI: 10.1016/j.clnesp.2024.04.024
    tissue_or_cell_type
    Intestinal absorption assessed from serial venous tracer measurements

    Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 465–476

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Seven healthy adult completers; three experimental days separated by one-month washouts · source_derived_draft · unverified_draft

    ### b12-abs-calcium-tracer-rescue Adding calcium 500 mg to metformin 850 mg raised mean tracer bioavailability from 30.8% to 46.4% in seven healthy completers (p=0.003). Condition category: normal nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: Calcium coadministration reversed the tracer reduction in this pilot. organism: Homo sapiens tissue_or_cell_type: Intestinal absorption assessed from serial venous tracer measurements experimental_model: Seven healthy adult completers; three experimental days separated by one-month washouts limitations: Small acute tracer pilot in healthy adults; cannot establish prevention of chronic deficiency or identify the exact molecular metformin target. Doses describe the experiment, not advice. exposure: Metformin 850 mg plus calcium 500 mg and carbon-13 cyanocobalamin cross_nutrient: true [muralidharan-2024-calcium] Effect of calcium supplementation on reversing metformin-based inhibition of vitamin B12 bioavailability in healthy adults using a [13C] cyanocobalamin tracer - A pilot study. (2024). https://pubmed.ncbi.nlm.nih.gov/38901951/ DOI: 10.1016/j.clnesp.2024.04.024
    Complete structured claim and evidence
  2. In seven healthy completers, tracer bioavailability averaged 30.8% with metformin 850 mg versus 42.6% on the control day (paired comparison p=0.010).

    Experimental context and source evidence
    cross_nutrient
    false
    experimental_model
    Seven healthy adult completers; three experimental days separated by one-month washouts
    exposure
    Oral carbon-13 cyanocobalamin with metformin 850 mg versus tracer alone
    limitations
    Small acute tracer pilot in healthy adults; cannot establish prevention of chronic deficiency or identify the exact molecular metformin target. Doses describe the experiment, not advice.
    nutrient_topic
    Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. · Vitamin B12 (cobalamins)
    organism
    Homo sapiens
    plain_language
    A single metformin exposure lowered measured B12 tracer availability.
    primary_references
    [muralidharan-2024-calcium] Effect of calcium supplementation on reversing metformin-based inhibition of vitamin B12 bioavailability in healthy adults using a [13C] cyanocobalamin tracer - A pilot study. (2024). https://pubmed.ncbi.nlm.nih.gov/38901951/ DOI: 10.1016/j.clnesp.2024.04.024
    tissue_or_cell_type
    Intestinal absorption assessed from serial venous tracer measurements

    Vitamin B12: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 452–463

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Seven healthy adult completers; three experimental days separated by one-month washouts · source_derived_draft · unverified_draft

    ### b12-abs-metformin-tracer In seven healthy completers, tracer bioavailability averaged 30.8% with metformin 850 mg versus 42.6% on the control day (paired comparison p=0.010). Condition category: normal nutrient_topic: Vitamin B12 research collection; topical membership is not evidence of a direct dietary effect. plain_language: A single metformin exposure lowered measured B12 tracer availability. organism: Homo sapiens tissue_or_cell_type: Intestinal absorption assessed from serial venous tracer measurements experimental_model: Seven healthy adult completers; three experimental days separated by one-month washouts limitations: Small acute tracer pilot in healthy adults; cannot establish prevention of chronic deficiency or identify the exact molecular metformin target. Doses describe the experiment, not advice. exposure: Oral carbon-13 cyanocobalamin with metformin 850 mg versus tracer alone cross_nutrient: false [muralidharan-2024-calcium] Effect of calcium supplementation on reversing metformin-based inhibition of vitamin B12 bioavailability in healthy adults using a [13C] cyanocobalamin tracer - A pilot study. (2024). https://pubmed.ncbi.nlm.nih.gov/38901951/ DOI: 10.1016/j.clnesp.2024.04.024
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards